Cargando…
Insulin-like growth factor-1: A potential target for bronchopulmonary dysplasia treatment (Review)
Bronchopulmonary dysplasia (BPD) is a common respiratory disorder among preterm infants, particularly low-birth-weight infants (LBWIs) and very-low-birth-weight infants (VLBWIs). Although BPD was first reported 50 years ago, no specific drugs or efficient measures are yet available for prevention or...
Autores principales: | Zhang, Shujian, Luan, Xue, Li, Huiwen, Jin, Zhengyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794548/ https://www.ncbi.nlm.nih.gov/pubmed/35126694 http://dx.doi.org/10.3892/etm.2022.11114 |
Ejemplares similares
-
The value of plasma insulin-like growth factor 1 and interleukin-18 in the diagnosis of bronchopulmonary dysplasia in premature infants
por: Huang, Lie, et al.
Publicado: (2022) -
NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020) -
Targeting vasculature to reduce fetal growth restriction associated bronchopulmonary dysplasia
por: Sehgal, Arvind, et al.
Publicado: (2022) -
The Role of Insulin Receptor Substrate Proteins in Bronchopulmonary Dysplasia and Asthma: New Potential Perspectives
por: Gorgisen, Gokhan, et al.
Publicado: (2022) -
Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)